To examine the potential role of TMED9 in GBM and provide support for the therapeutic applicability of the small molecule BRD4780, we analyzed available databases and investigated TMED9 expression in various brain tissues and astrocytic tumors. This evidence concerns the gene TMED9 and astrocytic tumor.